<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background/Aims: We tested the hypothesis that <z:hpo ids='HP_0011010'>chronic</z:hpo> hepatic <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e> could reduce the occurrence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> (CLM) and investigated CLM patients' survival prolonged in positive <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Methodology: 2868 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients were divided into positive-<z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and non-<z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> groups </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical variables, incidence of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> and survival between the groups were respectively analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>Results: The incidence of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> in the positive group was much lower than in the control group, but other type distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was similar in the two groups </plain></SENT>
<SENT sid="4" pm="."><plain>Infected group 5-year overall survival (OS) was better than the negative group </plain></SENT>
<SENT sid="5" pm="."><plain>Meanwhile, CLM patients in the former group showed longer survival time than the control group (26 months vs. 20 months, p&lt;0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Conclusions: <z:hpo ids='HP_0011010'>Chronic</z:hpo> hepatic <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> could reduce the occurrence of CLM and improves the survival time of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>It could be a protective factor for CLM patients </plain></SENT>
</text></document>